Vizora日本語

Perseus ProteomicsPerseus Proteomics Inc.4882東証グロース医薬品FY ending Mar 2026, non-consolidated, J-GAAP

Perseus Proteomics FY ending Mar 2026 results

Perseus Proteomics brought in ¥135.5M in revenue.

It lost about ¥550 for every ¥100 of sales at the operating level.

Revenue changed +12.6% from the prior year.

What changed from last year

FY ending Mar 2025 → FY ending Mar 2026

Revenue
+12.6%¥120.4M → ¥135.5M
Gross profit
+11.6%¥104.1M → ¥116.2M
Operating income
Loss-¥826.4M → -¥745M
Operating cash flow
Loss-¥719.5M → -¥653.3M
Free cash flow
Loss-¥794.6M → -¥663.3M

Where the money goes

FY ending Mar 2025 → FY ending Mar 2026

Where ¥100 of sales goes

For every ¥100 Perseus Proteomics sells, how much goes where, and how much is kept.

FY ending Mar 2026
Cost of sales
¥14
SG&A
¥636
Operating loss
¥550
Net loss
¥530

Annual margin trends

Gross margin85.7%
FY ending Mar 2021: 94.3%94.3%FY ending Mar 2022: 94.2%94.2%FY ending Mar 2023: 91.9%91.9%FY ending Mar 2024: 87.3%87.3%FY ending Mar 2025: 86.4%86.4%FY ending Mar 2026: 85.7%85.7%FY21FY22FY23FY24FY25FY26
Operating margin-549.8%
FY ending Mar 2021: -606.0%-606.0%FY ending Mar 2022: -656.4%-656.4%FY ending Mar 2023: -740.7%-740.7%FY ending Mar 2024: -891.1%-891.1%FY ending Mar 2025: -686.5%-686.5%FY ending Mar 2026: -549.8%-549.8%FY21FY22FY23FY24FY25FY26
Net margin-529.9%
FY ending Mar 2021: -608.1%-608.1%FY ending Mar 2022: -832.8%-832.8%FY ending Mar 2023: -835.4%-835.4%FY ending Mar 2024: -1100.0%-1100.0%FY ending Mar 2025: -751.7%-751.7%FY ending Mar 2026: -529.9%-529.9%FY21FY22FY23FY24FY25FY26

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    訂正有価証券報告書－第26期(2025/04/01－2026/03/31)

    ID S100YNJJ2026-06-30Open

  • EDINET (FSA Japan)

    有価証券報告書－第25期(2024/04/01－2025/03/31)

    ID S100W5TI2025-06-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第24期(2023/04/01－2024/03/31)

    ID S100TOCF2024-06-20Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第23期(2022/04/01－2023/03/31)

    ID S100S4VN2023-11-06Open

  • EDINET (FSA Japan)

    有価証券報告書－第22期(令和3年4月1日－令和4年3月31日)

    ID S100OCLP2022-06-23Open

  • EDINET (FSA Japan)

    有価証券報告書－第21期(令和2年4月1日－令和3年3月31日)

    ID S100LP5E2021-06-25Open

Extracted from XBRL: 40 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image